View Older Stories View More Recent Stories

May 4, 2020 08:05AM Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020
Apr 29, 2020 08:17AM Corbus Pharma (CRBP) Reports Publication of Results from Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial
Apr 29, 2020 08:05AM Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
Apr 29, 2020 08:05AM Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
Mar 12, 2020 07:05AM Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results
Mar 12, 2020 07:05AM Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results
Mar 10, 2020 08:05AM Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director
Mar 10, 2020 08:05AM Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director
Mar 5, 2020 08:05AM Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020
Mar 5, 2020 08:05AM Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020
Dec 9, 2019 08:05AM Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System
Dec 9, 2019 08:05AM Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System
Nov 18, 2019 08:29AM Corbus Pharma (CRBP) Reports Complete Enrollment of Ph. 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Nov 18, 2019 08:17AM Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Nov 18, 2019 08:17AM Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Nov 12, 2019 08:05AM Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
Nov 12, 2019 08:05AM Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
Nov 11, 2019 08:05AM Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
Nov 11, 2019 08:05AM Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
Nov 7, 2019 07:05AM Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
Nov 7, 2019 07:05AM Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
Nov 4, 2019 08:05AM Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
Nov 4, 2019 08:05AM Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
Oct 3, 2019 08:05AM Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
Oct 3, 2019 08:05AM Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
Aug 8, 2019 07:05AM Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 
Aug 8, 2019 07:05AM Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 
Aug 1, 2019 08:05AM Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2019 Operational and Financial Results on August 8, 2019
Aug 1, 2019 08:05AM Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2019 Operational and Financial Results on August 8, 2019
Jun 17, 2019 08:05AM Corbus Pharmaceuticals to Host 2019 R&D Day in New York City
Jun 17, 2019 08:05AM Corbus Pharmaceuticals to Host 2019 R&D Day in New York City
Jun 12, 2019 08:14AM Corbus Pharma (CRBP) Says Lenabasum Open-Label Extension Data to be Presented at EULAR Continue to Show Favorable Safety Profile and Improvement in Efficacy Outcomes
Jun 12, 2019 08:05AM Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Stu
Jun 12, 2019 08:05AM Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Stu
May 29, 2019 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June
May 29, 2019 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June
May 28, 2019 08:05AM Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting
May 28, 2019 08:05AM Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting
May 15, 2019 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
May 15, 2019 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
May 9, 2019 07:00AM Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates
May 9, 2019 07:00AM Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates
May 2, 2019 08:20AM Corbus Pharma (CRBP) Reports Complete Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
May 2, 2019 08:05AM Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
May 2, 2019 08:05AM Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
May 1, 2019 08:05AM Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 9, 2019
May 1, 2019 08:05AM Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 9, 2019
Apr 18, 2019 08:09AM Corbus Pharma (CRBP) Reports Change of Primary Endpoint in Ongoing RESOLVE-1 Phase 3 Study Following Meeting with FDA
Apr 18, 2019 08:05AM Corbus Pharmaceuticals Announces Change of Primary Endpoint in Ongoing RESOLVE-1 Phase 3 Study in Systemic Sclerosis in U.S. to ACR CRISS from mRSS Following Meeting with FDA
Apr 18, 2019 08:05AM Corbus Pharmaceuticals Announces Change of Primary Endpoint in Ongoing RESOLVE-1 Phase 3 Study in Systemic Sclerosis in U.S. to ACR CRISS from mRSS Following Meeting with FDA
View More Recent Stories View Older Stories